Kiryas Joel Businessman Owns Disreputable Milwaukee Drug Clinic
A month after regulators kicked a Milwaukee, Wisconsin drug treatment clinic out of the Medicaid program, another clinic opened in the same location. According to a new report from Milkwaukee television station FOX 6, both are owned by neighbors from the faraway Satmar Hasidic enclave of Kiryas Joel, New York.
“I don’t see how the state could have approved them and not see what is going on,” a employee of the first clinic told FOX 6. “At the end of the day these people are being taken advantage of and the taxpayers are paying for it.”
The first clinic, called Acacia Mental Health, is currently being sued by both the state of Wisoonsin and the federal government for filing false Medicaid claims. “He saw the clients as dollar signs,” a former employee of Acacia said of Abe Freund, the company’s owner.
After Acacia shut down in May, a new clinic opened at the same site the next month. FOX 6 reports that it shares much of its staff with Acacia. The new clinic is itself owned by a man named Netanel Friedman, who lives blocks from Freund in Kiryas Joel, according to FOX 6.
“Literally, they just posted a new banner on the building,” the former employee told the station.
Contact Josh Nathan-Kazis at nathankazis@forward.com or on Twitter, @joshnathankazis.
A message from our CEO & publisher Rachel Fishman Feddersen
I hope you appreciated this article. Before you move on, I wanted to ask you to support the Forward’s award-winning journalism during our High Holiday Monthly Donor Drive.
If you’ve turned to the Forward in the past 12 months to better understand the world around you, we hope you will support us with a gift now. Your support has a direct impact, giving us the resources we need to report from Israel and around the U.S., across college campuses, and wherever there is news of importance to American Jews.
Make a monthly or one-time gift and support Jewish journalism throughout 5785. The first six months of your monthly gift will be matched for twice the investment in independent Jewish journalism.
— Rachel Fishman Feddersen, Publisher and CEO